Kinross Gold Corp (KGC) 1.62 $KGC Watch for Kinross Gold

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Kinross Gold Corp (KGC) 1.62 $KGC

Watch for Kinross Gold to Potentially Rebound After Falling 6.90% Yesterday
Comtex SmarTrend(R) - Wed Aug 26, 4:47PM CDT
Kinross Gold (NYSE:KGC) traded in a range yesterday that spanned from a low of $1.62 to a high of $1.72. Yesterday, the shares fell 6.9%, which took the trading range below the 3-day low of $1.68 on volume of 9.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
KGC: 1.62 (-0.12)

Kinross Gold (KGC) Stock Falls Amid Lower Gold Prices
at The Street - Wed Aug 26, 9:57AM CDT
Kinross Gold (KGC) shares are lower as gold prices continue to fall for the second day in a row.
KGC: 1.62 (-0.12)

Kinross Gold (KGC) Stock Falling as Gold Prices Retreat
at The Street - Tue Aug 25, 10:56AM CDT
Kinross Gold (KGC) stock is down as the price of gold falls on a stronger dollar and global market recovery.
KGC: 1.62 (-0.12)

Downgrade Alert for Kinross Gold (KGC)
Comtex SmarTrend(R) - Mon Aug 24, 8:09AM CDT
Kinross Gold (NYSE:KGC) was downgraded from Sector Perform to Underperform at RBC Capital today. The stock closed yesterday at $2.07 on volume of 11.9 million shares, above average daily volume of 11.1 million. Kinross Gold has overhead space with shares priced $2.07, or 27.6% below the average consensus analyst price target of $2.86. Kinross Gold shares should encounter resistance at the 200-day moving average (MA) of $2.54 and support at the 50-day MA of $2.05.
KGC: 1.62 (-0.12)

Kinross Gold (KGC) Stock Higher on Jump in Gold Prices
at The Street - Thu Aug 20, 1:53PM CDT
Kinross Gold (KGC) stock is gaining as gold prices rally for a second consecutive day.
KGC: 1.62 (-0.12)

Goldcorp Stock Is Significantly Undervalued
Jack Foley - Amigobulls - Thu Aug 20, 6:29AM CDT
Goldcorp financials will see huge improvements in coming quarters and Goldcorp stock looks significantly undervalued with a $50 upside potential.
KGC: 1.62 (-0.12), NEM: 15.81 (-0.36), RGLD: 47.35 (-1.59), GG: 13.11 (-0.69)

Kinross Gold (KGC) Stock Gaining on Boost in Safe Haven Demand
at The Street - Wed Aug 19, 9:42AM CDT
Kinross Gold (KGC) stock is rising as gold price gain off of safe-haven demand.
KGC: 1.62 (-0.12)

Kinross Gold (KGC) Stock Falls Along With Gold Prices
at The Street - Tue Aug 18, 12:23PM CDT
Kinross Gold (KGC) shares are dropping as gold prices decline today.
KGC: 1.62 (-0.12)

Kinross Gold (KGC) Stock Gains on Rising Gold Prices
at The Street - Mon Aug 17, 11:38AM CDT
Kinross Gold (KGC) shares are higher as gold prices continue their recent gains.
KGC: 1.62 (-0.12)

2 Investor Filings Unearth Potential Gold
at The Street - Fri Aug 14, 11:00AM CDT
Mining recent 13Fs gives us an abundance of gold and silver, bank and insurance ideas.
AHL: 45.32 (+0.32), AUQ: 2.86 (+0.10), JXSB: 23.56 (-0.63), L: 35.79 (+0.43), NVSL: 10.74 (+0.01), FFNW: 11.88 (-0.03), LSBK: 13.33 (-0.67), KGC: 1.62 (-0.12), ANAT: 99.65 (+2.53), CBNJ: 10.97 (+0.28), NGD: 1.95 (-0.09), WAYN: 12.59 (-0.42), AGI: 3.52 (-0.29), AKG: 1.46 (-0.05), AUY: 1.76 (-0.12), CDE: 2.98 (-0.07), RFP: 9.21 (-0.06), CNA: 35.32 (+0.37)

Kinross Gold (KGC) Stock Tumbles on Lower Gold Prices
at The Street - Thu Aug 13, 1:37PM CDT
Shares of Kinross Gold (KGC) are down as gold prices fall on decreased global demand.
KGC: 1.62 (-0.12)

Kinross Gold (KGC) Stock Gained With Climbing Gold Prices
at The Street - Wed Aug 12, 3:39PM CDT
Kinross Gold (KGC) stock closed Wednesday's trading session up on heavy trading volume with increasing gold prices, due to the weak dollar and China's devaluation of the yuan.
KGC: 1.62 (-0.12)

Goldcorp (GG) Q2 Earnings, Revenues Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 04, 2:24PM CDT
Goldcorp Inc.'s (GG) second-quarter 2015 adjusted earnings (excluding one-time items) came in at $65 million or 8 cents per share, down from $164 million or 20 cents per share recorded in the year-ago quarter.
ABX: 6.55 (-0.44), KGC: 1.62 (-0.12), NEM: 15.81 (-0.36), GG: 13.11 (-0.69)

Kinross Gold (KGC) Stock Falls on Lower Gold Prices
at The Street - Mon Aug 03, 11:59AM CDT
Kinross Gold (KGC) shares are lower as gold prices decline.
KGC: 1.62 (-0.12)

Kinross Gold (KGC) Stock Popping on Rallying Gold Prices
at The Street - Fri Jul 31, 11:46AM CDT
Kinross Gold (KGC) stock is higher as gold prices rise to trade in positive territory.
KGC: 1.62 (-0.12)

Kinross Gold Reports Loss in Q2, Revenues Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 30, 1:20PM CDT
Gold miner Kinross Gold Corporation (KGC) reported a net loss of $83.2 million (or 7 cents per share) for the second quarter of 2015, as against net earnings of $46 million (or 4 cents per share) in the year-ago quarter.
KGC: 1.62 (-0.12), VGZ: 0.27 (-0.02), PPP: 2.65 (-0.15), ASM: 0.91 (-0.10)

Kinross reports 2015 second-quarter results
M2 - Thu Jul 30, 2:24AM CDT
Kinross Gold Corporation (TSX: K, NYSE: KGC) today announced its results for the second quarter ended June 30, 2015.
KGC: 1.62 (-0.12)

Kinross Gold reports 2Q loss
Automated Insights - Wed Jul 29, 6:42PM CDT
TORONTO (AP) _ Kinross Gold Corp. (KGC) on Wednesday reported a second-quarter loss of $83.2 million, after reporting a profit in the same period a year earlier.
K.TO: 2.16 (-0.14), KGC: 1.62 (-0.12)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading